Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$141.59 - $168.66 $7.86 Million - $9.37 Million
55,530 Added 10.75%
571,936 $89.2 Million
Q1 2022

May 16, 2022

BUY
$129.64 - $160.7 $66.9 Million - $83 Million
516,406 New
516,406 $80.4 Million
Q4 2018

Feb 14, 2019

SELL
$115.94 - $166.74 $111 Million - $160 Million
-958,025 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$161.01 - $180.57 $45.2 Million - $50.7 Million
-280,881 Reduced 22.67%
958,025 $161 Million
Q2 2018

Aug 14, 2018

BUY
$146.33 - $183.18 $15.1 Million - $18.9 Million
103,379 Added 9.1%
1,238,906 $213 Million
Q1 2018

May 15, 2018

BUY
$135.59 - $157.16 $154 Million - $178 Million
1,135,527 New
1,135,527 $171 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.7B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.